| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/26/2012 | US20120020878 Fusogenic properties of saposin c and related proteins and peptides for application to transmembrane drug delivery systems |
| 01/26/2012 | US20120020877 Process and intra-cervical device for the local release of drugs in the local-regional treatment of cervical cancer |
| 01/26/2012 | CA2806111A1 An ancestral serine protease coagulation cascade exerts a novel function in early immune defense |
| 01/26/2012 | CA2806058A1 Adverse side-effects associated with administration of anti-hyaluronan agents and methods for ameliorating or preventing the side-effects |
| 01/26/2012 | CA2805962A1 Crystal of peptide substance as well as the preparation method and use thereof |
| 01/26/2012 | CA2805753A1 Therapeutic protein compositions having reduced immunogenicity and/or improved efficacy |
| 01/26/2012 | CA2805673A1 Manufacture of active highly phosphorylated human n-acetylgalactosamine-6-sulfatase and uses thereof |
| 01/26/2012 | CA2804998A1 Peptide compounds for regulating the complement system |
| 01/26/2012 | CA2803948A1 Tubulysin analogues |
| 01/26/2012 | CA2803941A1 Method for producing autologous proteins |
| 01/25/2012 | EP2410331A1 Aminoacyl-tRNA synthetase for aminoacylation tRNA with unnatural amino acids |
| 01/25/2012 | EP2409985A2 Inhibitors de serine proteases, especially of the NS3 protease of the hepatitis C virus |
| 01/25/2012 | EP2409983A1 Tubulysin analogues |
| 01/25/2012 | EP2409711A1 Enzyme treatment of foodstuffs for celiac sprue |
| 01/25/2012 | EP2409710A1 Injectable material and material to be used as drug or food supplement for prophylaxis or treatment of osteoporosis |
| 01/25/2012 | EP2409709A1 Methods for regulation of stem cells |
| 01/25/2012 | EP2409707A1 Polymer-based sustained release device |
| 01/25/2012 | EP2409579A1 Antimicrobial peptide, branched forms and uses thereof for the cure of bacteria infections |
| 01/25/2012 | EP2409569A2 Method for administering GLP-1 molecules |
| 01/25/2012 | EP2409152A1 Methods for modulating circadian rythms |
| 01/25/2012 | EP2408905A2 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
| 01/25/2012 | EP2408811A1 Methods and compositions for modulating cardiac contractility |
| 01/25/2012 | EP2408809A1 Peptides modulating the activity of igf-1 and the applications of said peptides |
| 01/25/2012 | EP2408808A1 Terminally-functionalized conjugates and uses thereof |
| 01/25/2012 | EP2408803A1 Inhibitors of viral integrase and methods of use |
| 01/25/2012 | EP2408801A1 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions |
| 01/25/2012 | EP2408758A1 Crystalline tripeptide epoxy ketone protease inhibitors |
| 01/25/2012 | EP2408472A2 Use of somatostatin or an analogue thereof in combination with external radiation therapy |
| 01/25/2012 | EP2408471A1 Targets for growth factor signalling and methods of therapy |
| 01/25/2012 | EP2408470A1 Soluble non-depot insulin conjugates and uses thereof |
| 01/25/2012 | EP2408469A1 Use of decorin for increasing muscle mass |
| 01/25/2012 | EP2408468A2 USE OF NKp46 FOR PREVENTING DIABETES |
| 01/25/2012 | EP2408467A2 A method and composition using a dual specificity protein tyrosine phosphatase as an antimalarial drug target |
| 01/25/2012 | EP2408466A2 Agents and methods for tissue repair and regeneration |
| 01/25/2012 | EP2408465A2 Methods and compositions for the detection of cancer |
| 01/25/2012 | EP2408464A2 Hcv-derived polypeptides and uses thereof |
| 01/25/2012 | EP2408463A2 Methods for the prevention and treatment of burn injuries and secondary complications |
| 01/25/2012 | EP2408462A1 Targeted delivery of chemotherapeutic agents |
| 01/25/2012 | EP2408455A2 Inhibitors of cathepsin s for prevention or treatment of obesity-associated disorders |
| 01/25/2012 | EP2408444A2 Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same |
| 01/25/2012 | EP2408434A1 Treating alzheimer's disease and osteoporosis and reducing aging |
| 01/25/2012 | EP2208734B1 Food material for inhibiting the formation of osteoclast |
| 01/25/2012 | EP2187926B1 Prevention of diabetes by administration of gliadin |
| 01/25/2012 | EP2144623B1 Process for the manufacture of a dairy-based anti-inflammatory composition |
| 01/25/2012 | EP2114924B1 Co-crystals and pharmaceutical compositions comprising the same |
| 01/25/2012 | EP1993672B1 Use of cardiotonic steroids as Na/K-ATPase ligands for the treatment of the skin |
| 01/25/2012 | EP1904635B1 Glycosylated il-7, preparation and uses |
| 01/25/2012 | EP1836314B1 Modified human growth hormone |
| 01/25/2012 | EP1725245B1 Manganese and iron based compounds for elastogenesis and connective tissue treatment |
| 01/25/2012 | EP1687018B1 Hepatitis c virus inhibitors |
| 01/25/2012 | EP1440157B1 Methods and means for producing proteins with predetermined post-translational modifications |
| 01/25/2012 | EP1434597B1 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 01/25/2012 | EP1351707B9 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 01/25/2012 | EP1192253B1 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 01/25/2012 | EP1019437B1 Method for the covalent attachment of polysaccharides to protein molecules |
| 01/25/2012 | CN1982330B Methods for preparing purified lipopeptides |
| 01/25/2012 | CN1981872B Use of PUMA in tumor chemoradiotherapy sensibilization |
| 01/25/2012 | CN1558759B 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 01/25/2012 | CN102333788A Modification of factor viii |
| 01/25/2012 | CN102333546A Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 01/25/2012 | CN102333537A Methods of treating retinitis pigmentosa |
| 01/25/2012 | CN102333536A Ss-arrestin effectors and compositions and methods of use thereof |
| 01/25/2012 | CN102333520A Prophylactic/therapeutic agent for cancer |
| 01/25/2012 | CN102329803A Portunus trituberculatus antilipopolysaccharide factor PtALF-6 gene and coding protein and applications thereof |
| 01/25/2012 | CN102329802A Portunus trituberculatus antilipopolysaccharide factor PtALF-4 gene and coding protein and applications thereof |
| 01/25/2012 | CN102329801A Portunus trituberculatus anti-lipopolysaccharide factor PtALF-1 gene, protein encoded by gene and application of protein |
| 01/25/2012 | CN102329714A Method for manufacturing and using high-activity SOD (Superoxide Dismutase) product |
| 01/25/2012 | CN102329386A Achistosoma japonica Ago protein, gene, micro RNA (Ribonucleic Acid) and application thereof |
| 01/25/2012 | CN102329385A Anti-apoptotic protein in schistosoma japonicum |
| 01/25/2012 | CN102329376A Cyclo(phenylalanine-N-methylleucyl-leucyl-N-methylleucyl-leucyl), and synthesis method and application thereof |
| 01/25/2012 | CN102329375A Group of terminal-amidated antibacterial peptides |
| 01/25/2012 | CN102329246A Multiple-target-point tamibarotene derivatives, preparation method and purposes thereof |
| 01/25/2012 | CN102327613A Application of ErbB receptor stimulant to preparation of medicament for treating epilepsy |
| 01/25/2012 | CN102327602A Pharmaceutical composition comprising botulinum, a non ionicsurfactant, sodium chloride and sucrose |
| 01/25/2012 | CN102327601A Hemostat for resisting infection and promoting wound healing and preparation method thereof |
| 01/25/2012 | CN102327600A RX31 peptide for preventing and curing radiation damage |
| 01/25/2012 | CN102327599A Composition and method for use in treating myelodysplastic syndrome |
| 01/25/2012 | CN102327598A Composition and method for use in treating myelodysplastic syndrome |
| 01/25/2012 | CN102327243A Pidotimod chewable tablet |
| 01/25/2012 | CN102327242A Polyethylene glycol-integrated interferon variant lyophilized preparation |
| 01/25/2012 | CN102327241A Polyethylene glycol-integrated interferon variant freeze-dried preparation |
| 01/25/2012 | CN102327239A Salmon calcitonin nano liposome injection and preparation method thereof |
| 01/25/2012 | CN102327229A Pidotimod dry suspension |
| 01/25/2012 | CN102151251B Method for freeze-drying reduced glutathione for injection |
| 01/25/2012 | CN101906146B Conjugate produced by coupling Arg-Gly-Asp-Ser chain with two fatty alcohol chains through Asp, synthesis of Arg-Gly-Asp-Ser chain and fatty alcohol chains and application in medicine |
| 01/25/2012 | CN101906137B Conjugate of Arg-Gly-Asp chain and two fatty alcohol chains, synthesis and medical application thereof |
| 01/25/2012 | CN101797377B Fibrin sealant and preparation method thereof |
| 01/25/2012 | CN101747414B Tumor necrosis factor (TNF)-alpha binding peptide and tumor necrosis factor receptor 1(TNFR1) blocking peptide and applications thereof in treatment of TNF related diseases |
| 01/25/2012 | CN101721677B Thymopentin oral microsphere preparation and preparation method thereof |
| 01/25/2012 | CN101683519B Composition of thymic peptide alpha 1 and thymopeptide-5 and preparation method thereof |
| 01/25/2012 | CN101525610B Application of earthworm fibronectin enzyme in treating hepatitis B |
| 01/25/2012 | CN101301467B Uses of BMP-7 in preparing medicament for preventing and/or treating liver fibrosis |
| 01/25/2012 | CN101255197B Fusion protein for serum albumin and interleukin 1 receptor antagonist and uses thereof |
| 01/25/2012 | CN101240015B Core-peptide composition with physiological activity and its preparation method and application |
| 01/25/2012 | CN101220088B Amalgamation protein of human glucagons-like peptide-1 and uses thereof |
| 01/25/2012 | CN101085813B Soluble TNF acceptor mutant |
| 01/24/2012 | USRE43140 Immunoregulator |
| 01/24/2012 | US8103517 System and method to improve fitness training |
| 01/24/2012 | US8101742 Method and medicament for inhibiting the expression of a given gene |
| 01/24/2012 | US8101738 ABFB-2 gene from Penicillium funiculosum |